PIK3CA and neoplasm: The stem cell-like properties of these CT-2A tumor cells demonstrate a highly immune suppressive TME as reported by Khalsa et al (117); tumor cells are deficient in PTEN and have a dysregulated PI3K pathway which makes them useful to evaluate PTEN and/or PI3K signaling effects (22).